'Rosiglitazone' presentation slideshows

Rosiglitazone - PowerPoint PPT Presentation

Fatty Liver Disease

Fatty Liver Disease

Fatty Liver Disease. Jamie Blazek, MPH, APRN, FNP-C Liver Transplant Department Ochsner Health Systems New Orleans, La. Disclosures. None. Objectives. Identify risk factors for fatty liver disease Order appropriate screening tests Diagnose and treat fatty liver disease

★ ★ ★ ★ ★

1.58k views • 63 slides
DREAM

DREAM

DREAM. D iabetes RE duction A ssessment with ramipril and rosiglitazone M edication. Prevention of Type 2 Diabetes. Clinical trials have shown that diet & exercise can prevent diabetes by > 50% in people with impaired glucose tolerance (IGT)

★ ★ ★ ★ ★

567 views • 44 slides
Agenda: TZDs Overview Pioglitazone and Diabetes Rosiglitazone and Diabetes

Agenda: TZDs Overview Pioglitazone and Diabetes Rosiglitazone and Diabetes

Agenda: TZDs Overview Pioglitazone and Diabetes Rosiglitazone and Diabetes Pioglitazone vs. Rosiglitazone TZDs Fracture Data TZDs and Cancer Summary. Pioglitazone [ Actos ] : 15/30/45 mg Rosiglitazone [ Avandia ]: 4mg/bid

★ ★ ★ ★ ★

396 views • 38 slides
Testimony of Sidney Wolfe M.D., Elizabeth Barbehenn Ph.D. and Ben Wolpaw

Testimony of Sidney Wolfe M.D., Elizabeth Barbehenn Ph.D. and Ben Wolpaw

Testimony of Sidney Wolfe M.D., Elizabeth Barbehenn Ph.D. and Ben Wolpaw Health Research Group of Public Citizen FDA Endocrine Metabolic Drugs Advisory Committee Meeting on Rosiglitazone: July 30, 2007. 4. Does the overall risk-benefit profile of Avandia

★ ★ ★ ★ ★

373 views • 23 slides
Selected and summarized by Jeffrey P. Nadler, MD, FACP USF College of Medicine Tampa, Florida

Selected and summarized by Jeffrey P. Nadler, MD, FACP USF College of Medicine Tampa, Florida

Antiretroviral Treatment Highlights of the 11th Conference on Retroviruses and Opportunistic Infections (CROI) February 8-11, 2004; San Francisco, California. Selected and summarized by Jeffrey P. Nadler, MD, FACP USF College of Medicine Tampa, Florida.

★ ★ ★ ★ ★

445 views • 17 slides
Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy

Glycemic Durability of Rosiglitazone, Metformin, or Glyburide Monotherapy.

★ ★ ★ ★ ★

291 views • 11 slides
Fasting HDL (mg/dL) Fasting LDL (mg/dL) Fasting TG (mg/dL)

Fasting HDL (mg/dL) Fasting LDL (mg/dL) Fasting TG (mg/dL)

Fasting Insulin (mU/L) Fasting Glucose (mg/dL) Study N WMD (95% CI) WMD (95% CI). Rosiglitazone vs. Metformin Mulligan 53 van Wijk/Coll 31 Tomazic 60 Overall 144. -1.02 (-3.99, 1.94). 1.09 (-2.48, 4.65).

★ ★ ★ ★ ★

245 views • 1 slides

View Rosiglitazone PowerPoint (PPT) presentations online in SlideServe. SlideServe has a very huge collection of Rosiglitazone PowerPoint presentations. You can view or download Rosiglitazone presentations for your school assignment or business presentation. Browse for the presentations on every topic that you want.